JD Supra6d
Compounding and GLP-1s: What To Expect When GLP-1 Drugs Are Removed From FDA’s Drug Shortage List
What Are GLP-1s? Glucagon-like peptide-1 receptor agonists, also known as GLP-1 drugs, are a class of medications that mimic the action of ...
STAT27d
The FDA’s risky action on compounding weight loss drugs
Compounding serves a vital role by enabling pharmacies to tailor medications to the specific needs of individual patients when commercially available drugs are insufficient — for example ...
BioPharma Dive13d
Diabetes advocacy group discourages use of compounded GLP-1 drugs
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...
Medscape18d
FDA Responds to Supreme Court Decision on Advertising of Compounded Drugs
A prohibition on advertising compounded drugs would, for example, prevent a pharmacist from informing a pediatrician about a compounding process that allowed a drug, previously available only as a ...
NBC Los Angeles27d
FDA weighs in on diet drug shortage, creating more confusion about compounding
The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients ...